|
| |
United TherapeuticsUnited Therapeutics is a biotechnology company focused on the development and commercialization of unique products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases. In these segments, United Therapeutics is actively developing four technology platforms: Prostacyclin Analogs, Immunotherapeutic Monoclonal Antibodies, Glycobiology, and Telemedicine.
At United Therapeutics, we find tremendous inspiration for our work and view our products as being new beginnings for patients and doctors, with quality of life as our utmost therapeutic goal. The theme of United Therapeutics is "Medicines for Life" because all of our therapeutics address life-threatening illnesses.
| Contact Details: |
| 1110 Spring Street |
| Silver Spring |
| MD |
| 20910 |
| United States of America |
| Tel: | 301 608 9292 |
| Fax: | 301.608.9291 |
| Email: | webmaster@unither.com |
| WWW: | www.unither.com/
|
|
Loading...
|
Recent Publications by United Therapeutics: |  |
Dose proportionality of treprostinil sodium administered by continuous subcutaneous and intravenous infusion.
This study assessed the relationship between dose and plasma concentration... | 19th April, 2008
| Clinical Affairs, United Therapeutics Corporation, One Park Drive, 4th
| J Clin Pharmacol. 2008 Jan;48(1):19-25.
DOI Direct Link |
Treprostinil for the treatment of pulmonary arterial hypertension in patients with New York Heart Association class II-IV symptoms.
This study assessed the relationship between dose and plasma concentration... | 9th December, 2006
| United Therapeutics Corporation, Research Triangle Park, North Carolina
| Pharmacotherapy. 2006 Aug;26(8):1203; discussion 1203-4.
DOI Direct Link |
Pharmacokinetics and steady-state bioequivalence of treprostinil sodium (Remodulin) administered by the intravenous and subcutaneous route to normal volunteers.
Treprostinil sodium is a chemically stable analogue of prostacyclin... | 29th April, 2005
| United Therapeutics Corporation, Research Triangle Park, North Carolina
| J Cardiovasc Pharmacol. 2004 Aug;44(2):209-14.
|
Pulmonary hypertension.
Pulmonary hypertension, in its simplest sense, is elevation of the... | 26th February, 2005
|
| Curr Probl Cardiol. 2004 Oct;29(10):575-634.
DOI Direct Link |
Pharmacokinetics of treprostinil sodium administered by 28-day chronic continuous subcutaneous infusion.
The objective of this study was to assess the pharmacokinetics and safety... | 17th December, 2004
| United Therapeutics Corporation, One Park Drive, P.O. Box 14186, Research
| J Clin Pharmacol. 2004 May;44(5):503-9.
DOI Direct Link |
→View more United Therapeutics research publications. |
Press Releases on United Therapeutics:
|
 |
| United Therapeutics Corporation Reports Third Quarter 2009 Financial Results |
29th October, 2009 |
United Therapeutics Corporation |
SILVER SPRING, Md., Oct. 29 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its results of operations for the quarter ended September 30, 2009.
Revenues for
|
| United Therapeutics Corporation to Announce Third Quarter 2009 Financial Results Before Market Open on Thursday, October 29, 2009 |
22nd October, 2009 |
United Therapeutics Corporation |
SILVER SPRING, Md., Oct. 22 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will release its 2009 third quarter financial results before market open on
|
| Prix Galien USA Announces 2009 Final Candidates |
7th August, 2009 |
Prix Galien USA |
-- Wyeth, TORISEL(R)
Best Biotechnology Product:
-- Amgen, Nplate(R)
-- GlaxoSmithKline, PROMACTA(R) and Tykerb(R)
-- Schering-Plough, PEGINTRON(R)
-- Tibotec, INTELENCE(TM
|
| New Report Just Published: World Telemedicine Market Report |
7th July, 2009 |
Reportlinker |
NEW YORK, July 7 /PRNewswire/ -- Reportlinker.com just added a new market research report to its catalogue.
World Telemedicine Market
http://www.reportlinker.com/p0119470/World-Telemedicine-Market
|
| Shawn Cross Joins Burrill Merchant Banking |
18th June, 2009 |
Burrill & Company |
SAN FRANCISCO, June 18 /PRNewswire/ -- Burrill & Company, a San Francisco-based global leader in life sciences with activities in Venture Capital, Private Equity, Merchant Banking and Media, is
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 579 times since April 2007, the link to the organisation's website has been followed 74 times Recent Search Terms used to find this page: united therapeutics uk | UNITED THERAPEUTICS UK | united therapeutics patents | tyvaso june2009 | united therapeutics patents | united therapeutics patents | united therapeutics | research triangle park united therapeutics new building | united therapeutics building | . Search for more companies in Silver Spring Search for more companies in MD This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for United Therapeutics |
